A carregar...
Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
INTRODUCTION: Major cardiovascular risk factors, including hypertension and dyslipidemia, are often comorbidities, frequently leading to concurrent prescription of angiotensin receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins). The study’s objective was to eva...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6063220/ https://ncbi.nlm.nih.gov/pubmed/30087555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S165171 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|